Disease Markers / 2020 / Article / Fig 1

Research Article

Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer

Figure 1

Serum SPRR2A levels in the five groups of subjects. Serum SPRR2A expression levels in the gastric cancer group (at 124.10 (82.73, 186.05)) were significantly higher than those in the gastritis group (at 50.07 (30.57, 87.54)), the colon cancer group (at 62.04 (51.56, 78.59)), the rectal cancer group (at 56.58 (41.17, 75.20)), and the healthy control group (at 44.93 (28.54, 74.27)) (, all). There was no difference in the serum SPRR2A concentration between healthy controls and patients with gastritis, colon cancer, or rectal cancer (, , and , respectively).

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.